USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
PHARMABRIDGE, INC.
Address:
3805 OLD EASTON ROAD
DOYLESTOWN, PA
Phone:
N/A
URL:
N/A
EIN:
120470935
DUNS:
787949390
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $240,146.00 1
SBIR Phase II $3,000,000.00 1

Award List:

Novel HBV Therapeutic with Potential for Treatment of Drug-Resistant Infection

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$240,146.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Our proposal centers on the development of a novel antiviral compound for therapy of hepatitis B patients. Hepatitis B surface antigen (HBsAg) is an essential viral gene product, and its high levels in the circulation m ay play a role in immunosuppression.… More

Novel HBV Therapeutic with Potential for Treatment of Drug-Resistant Infection

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$3,000,000.00
Agency:
HHS
Principal Investigator:
Andrea Cuconati – 215-489-4918
Abstract:
DESCRIPTION (provided by applicant): This is a Phase II proposal to advance development of disubstituted tetrahydro-triazolo-pyrimidines (TTPs) as specific inhibitors of hepatitis B virus surface antigen (HBsAg) secretion in chronic infection. High serum levels of HBsAg (antigenemia) are believed to… More